 Tor Wager
Concepts (491)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain | 79 | 2025 | 751 | 17.850 |
Why?
| | Brain | 142 | 2025 | 2624 | 17.150 |
Why?
| | Brain Mapping | 97 | 2024 | 572 | 13.900 |
Why?
| | Magnetic Resonance Imaging | 145 | 2025 | 3387 | 10.300 |
Why?
| | Pain Perception | 21 | 2025 | 40 | 8.710 |
Why?
| | Placebo Effect | 31 | 2024 | 55 | 8.200 |
Why?
| | Emotions | 40 | 2024 | 535 | 7.640 |
Why?
| | Chronic Pain | 20 | 2025 | 254 | 5.910 |
Why?
| | Neuroimaging | 28 | 2024 | 279 | 4.690 |
Why?
| | Analgesia | 14 | 2024 | 92 | 4.580 |
Why?
| | Pain Measurement | 28 | 2024 | 488 | 4.550 |
Why?
| | Prefrontal Cortex | 28 | 2024 | 302 | 4.430 |
Why?
| | Pain Management | 16 | 2025 | 321 | 4.190 |
Why?
| | Image Processing, Computer-Assisted | 29 | 2022 | 737 | 3.840 |
Why?
| | Nerve Net | 24 | 2025 | 256 | 3.640 |
Why?
| | Neural Pathways | 22 | 2025 | 297 | 3.600 |
Why?
| | Functional Neuroimaging | 20 | 2024 | 73 | 3.270 |
Why?
| | Cognition | 25 | 2025 | 1110 | 3.160 |
Why?
| | Nociception | 11 | 2024 | 22 | 3.150 |
Why?
| | Affect | 14 | 2024 | 284 | 2.920 |
Why?
| | Memory, Short-Term | 13 | 2024 | 258 | 2.890 |
Why?
| | Back Pain | 6 | 2024 | 51 | 2.740 |
Why?
| | Empathy | 11 | 2023 | 170 | 2.620 |
Why?
| | Models, Neurological | 12 | 2021 | 240 | 2.530 |
Why?
| | Meditation | 8 | 2024 | 38 | 2.490 |
Why?
| | Social Behavior | 8 | 2019 | 288 | 2.480 |
Why?
| | Learning | 11 | 2022 | 399 | 2.470 |
Why?
| | Young Adult | 83 | 2025 | 12349 | 2.420 |
Why?
| | Humans | 279 | 2025 | 128495 | 2.410 |
Why?
| | Interpersonal Relations | 7 | 2020 | 390 | 2.400 |
Why?
| | Cerebral Cortex | 22 | 2024 | 423 | 2.320 |
Why?
| | Galvanic Skin Response | 9 | 2021 | 32 | 2.230 |
Why?
| | Pain Threshold | 10 | 2024 | 71 | 2.210 |
Why?
| | Periaqueductal Gray | 7 | 2024 | 17 | 2.160 |
Why?
| | Adult | 118 | 2025 | 35299 | 2.130 |
Why?
| | Attention | 16 | 2025 | 433 | 2.060 |
Why?
| | Cues | 13 | 2025 | 325 | 2.030 |
Why?
| | Nociceptive Pain | 3 | 2024 | 5 | 1.870 |
Why?
| | Male | 137 | 2025 | 63043 | 1.810 |
Why?
| | Mindfulness | 5 | 2024 | 116 | 1.780 |
Why?
| | Female | 139 | 2025 | 68266 | 1.760 |
Why?
| | Neurosciences | 5 | 2024 | 29 | 1.720 |
Why?
| | Machine Learning | 10 | 2024 | 444 | 1.690 |
Why?
| | Amygdala | 11 | 2024 | 193 | 1.660 |
Why?
| | Heart Rate | 5 | 2019 | 798 | 1.640 |
Why?
| | Stress, Psychological | 12 | 2024 | 1064 | 1.630 |
Why?
| | Bayes Theorem | 6 | 2025 | 373 | 1.580 |
Why?
| | Fear | 13 | 2022 | 347 | 1.540 |
Why?
| | Image Interpretation, Computer-Assisted | 11 | 2020 | 253 | 1.520 |
Why?
| | Hot Temperature | 13 | 2024 | 359 | 1.510 |
Why?
| | Social Perception | 5 | 2023 | 104 | 1.480 |
Why?
| | Gyrus Cinguli | 9 | 2020 | 79 | 1.450 |
Why?
| | Fibromyalgia | 6 | 2023 | 55 | 1.440 |
Why?
| | Visual Perception | 6 | 2025 | 162 | 1.440 |
Why?
| | Touch | 3 | 2020 | 34 | 1.360 |
Why?
| | Conditioning, Classical | 5 | 2022 | 112 | 1.340 |
Why?
| | Anticipation, Psychological | 4 | 2019 | 22 | 1.330 |
Why?
| | Trust | 3 | 2023 | 116 | 1.180 |
Why?
| | Frontal Lobe | 7 | 2018 | 153 | 1.090 |
Why?
| | Functional Laterality | 5 | 2019 | 218 | 1.080 |
Why?
| | Phobia, Social | 3 | 2023 | 13 | 1.070 |
Why?
| | Physician-Patient Relations | 4 | 2023 | 530 | 1.050 |
Why?
| | Placebos | 9 | 2024 | 201 | 1.040 |
Why?
| | Artifacts | 7 | 2021 | 123 | 1.030 |
Why?
| | Association Learning | 2 | 2017 | 66 | 1.020 |
Why?
| | Biomarkers | 12 | 2025 | 3893 | 1.010 |
Why?
| | Reproducibility of Results | 15 | 2023 | 3021 | 1.000 |
Why?
| | Analgesics, Opioid | 7 | 2020 | 889 | 1.000 |
Why?
| | Low Back Pain | 3 | 2023 | 102 | 0.990 |
Why?
| | Reward | 10 | 2023 | 237 | 0.970 |
Why?
| | Models, Statistical | 9 | 2024 | 622 | 0.950 |
Why?
| | Physical Stimulation | 10 | 2019 | 74 | 0.940 |
Why?
| | Mental Processes | 4 | 2016 | 38 | 0.930 |
Why?
| | Transcranial Direct Current Stimulation | 1 | 2024 | 4 | 0.920 |
Why?
| | Individuality | 8 | 2021 | 156 | 0.910 |
Why?
| | Corpus Striatum | 3 | 2019 | 158 | 0.880 |
Why?
| | Meta-Analysis as Topic | 7 | 2018 | 169 | 0.870 |
Why?
| | Irritable Bowel Syndrome | 3 | 2023 | 28 | 0.860 |
Why?
| | Culture | 3 | 2020 | 124 | 0.860 |
Why?
| | Adolescent | 40 | 2024 | 20304 | 0.850 |
Why?
| | Self-Control | 3 | 2019 | 55 | 0.850 |
Why?
| | Visual Cortex | 2 | 2019 | 68 | 0.830 |
Why?
| | Fraud | 1 | 2023 | 9 | 0.830 |
Why?
| | Nocebo Effect | 5 | 2021 | 9 | 0.830 |
Why?
| | Algorithms | 10 | 2022 | 1614 | 0.810 |
Why?
| | Psychomotor Performance | 12 | 2021 | 312 | 0.800 |
Why?
| | Middle Aged | 41 | 2024 | 30921 | 0.800 |
Why?
| | Social Learning | 2 | 2023 | 5 | 0.790 |
Why?
| | Head | 1 | 2023 | 96 | 0.770 |
Why?
| | Cross-Over Studies | 1 | 2024 | 509 | 0.770 |
Why?
| | Problem Solving | 1 | 2023 | 154 | 0.760 |
Why?
| | Behavior | 5 | 2021 | 92 | 0.760 |
Why?
| | Pulvinar | 1 | 2021 | 4 | 0.750 |
Why?
| | Semantics | 2 | 2021 | 100 | 0.730 |
Why?
| | Neurons | 3 | 2020 | 1447 | 0.730 |
Why?
| | Ego | 1 | 2021 | 11 | 0.730 |
Why?
| | Shoulder Pain | 1 | 2021 | 31 | 0.720 |
Why?
| | Superior Colliculi | 1 | 2021 | 37 | 0.720 |
Why?
| | Extinction, Psychological | 4 | 2016 | 88 | 0.710 |
Why?
| | Stereotyping | 1 | 2021 | 46 | 0.700 |
Why?
| | Oxygen | 10 | 2018 | 901 | 0.700 |
Why?
| | Guilt | 1 | 2020 | 12 | 0.690 |
Why?
| | Sexual Partners | 2 | 2019 | 185 | 0.680 |
Why?
| | Sexism | 1 | 2021 | 55 | 0.680 |
Why?
| | Photic Stimulation | 13 | 2021 | 239 | 0.680 |
Why?
| | Psychophysiology | 4 | 2011 | 16 | 0.680 |
Why?
| | Computer Simulation | 10 | 2019 | 939 | 0.670 |
Why?
| | Depressive Disorder, Major | 6 | 2023 | 344 | 0.670 |
Why?
| | Nucleus Accumbens | 3 | 2017 | 126 | 0.670 |
Why?
| | Executive Function | 8 | 2025 | 424 | 0.670 |
Why?
| | Biomedical Technology | 1 | 2020 | 40 | 0.660 |
Why?
| | Movement | 2 | 2020 | 269 | 0.660 |
Why?
| | Motivation | 8 | 2023 | 545 | 0.650 |
Why?
| | Mental Recall | 3 | 2016 | 190 | 0.650 |
Why?
| | Consensus | 4 | 2021 | 610 | 0.650 |
Why?
| | Motor Cortex | 4 | 2024 | 58 | 0.640 |
Why?
| | Pleasure | 2 | 2024 | 20 | 0.640 |
Why?
| | Arousal | 6 | 2021 | 150 | 0.630 |
Why?
| | Healthy Volunteers | 8 | 2024 | 199 | 0.620 |
Why?
| | Models, Psychological | 3 | 2017 | 307 | 0.600 |
Why?
| | Pattern Recognition, Automated | 2 | 2015 | 73 | 0.590 |
Why?
| | Diagnostic Imaging | 8 | 2010 | 332 | 0.590 |
Why?
| | Neuralgia | 1 | 2020 | 119 | 0.590 |
Why?
| | Reaction Time | 11 | 2019 | 407 | 0.590 |
Why?
| | Analgesics | 5 | 2024 | 166 | 0.590 |
Why?
| | Nonlinear Dynamics | 4 | 2017 | 88 | 0.580 |
Why?
| | Mental Disorders | 4 | 2022 | 1007 | 0.580 |
Why?
| | Language | 2 | 2017 | 280 | 0.570 |
Why?
| | Piperidines | 3 | 2013 | 191 | 0.560 |
Why?
| | Suggestion | 1 | 2017 | 3 | 0.560 |
Why?
| | Pattern Recognition, Physiological | 1 | 2017 | 2 | 0.550 |
Why?
| | Brain Stem | 2 | 2018 | 98 | 0.550 |
Why?
| | Acute Pain | 3 | 2024 | 45 | 0.550 |
Why?
| | Evoked Potentials | 3 | 2007 | 116 | 0.540 |
Why?
| | Natural Language Processing | 2 | 2024 | 94 | 0.530 |
Why?
| | Somatosensory Cortex | 3 | 2019 | 34 | 0.530 |
Why?
| | Social Support | 1 | 2020 | 589 | 0.520 |
Why?
| | Depressive Disorder | 2 | 2017 | 355 | 0.510 |
Why?
| | Stress, Physiological | 2 | 2016 | 413 | 0.510 |
Why?
| | Helping Behavior | 1 | 2016 | 18 | 0.510 |
Why?
| | Anxiety | 7 | 2021 | 952 | 0.510 |
Why?
| | Health Status | 1 | 2021 | 747 | 0.500 |
Why?
| | Family Characteristics | 1 | 2017 | 178 | 0.500 |
Why?
| | Stress Disorders, Post-Traumatic | 7 | 2019 | 821 | 0.500 |
Why?
| | Research | 1 | 2018 | 409 | 0.490 |
Why?
| | Forecasting | 2 | 2015 | 356 | 0.470 |
Why?
| | Mental Health | 1 | 2021 | 683 | 0.460 |
Why?
| | Connectome | 6 | 2022 | 84 | 0.460 |
Why?
| | Social Discrimination | 1 | 2014 | 12 | 0.460 |
Why?
| | Facial Expression | 4 | 2024 | 71 | 0.460 |
Why?
| | Abdominal Pain | 1 | 2015 | 144 | 0.440 |
Why?
| | Tomography, Emission-Computed | 5 | 2004 | 66 | 0.440 |
Why?
| | Autonomic Nervous System | 5 | 2021 | 75 | 0.440 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 53 | 0.430 |
Why?
| | Positron-Emission Tomography | 4 | 2015 | 283 | 0.430 |
Why?
| | Citalopram | 3 | 2019 | 30 | 0.420 |
Why?
| | Models, Theoretical | 3 | 2019 | 542 | 0.410 |
Why?
| | Central Nervous System | 1 | 2015 | 254 | 0.410 |
Why?
| | Hemodynamics | 4 | 2013 | 1077 | 0.400 |
Why?
| | Perception | 2 | 2017 | 336 | 0.400 |
Why?
| | Imagination | 2 | 2018 | 16 | 0.400 |
Why?
| | Negotiating | 1 | 2012 | 30 | 0.390 |
Why?
| | Neurofeedback | 2 | 2024 | 4 | 0.390 |
Why?
| | Memory, Long-Term | 1 | 2012 | 13 | 0.390 |
Why?
| | Gray Matter | 3 | 2024 | 82 | 0.390 |
Why?
| | Minority Groups | 1 | 2014 | 250 | 0.390 |
Why?
| | Haplorhini | 1 | 2012 | 50 | 0.390 |
Why?
| | Depression | 2 | 2019 | 1292 | 0.380 |
Why?
| | Social Desirability | 1 | 2011 | 15 | 0.370 |
Why?
| | Brain Chemistry | 2 | 2012 | 115 | 0.370 |
Why?
| | Video Recording | 3 | 2021 | 161 | 0.360 |
Why?
| | Neuropsychological Tests | 10 | 2024 | 1005 | 0.360 |
Why?
| | Mood Disorders | 1 | 2012 | 118 | 0.360 |
Why?
| | Antidepressive Agents | 4 | 2019 | 223 | 0.360 |
Why?
| | Proof of Concept Study | 2 | 2024 | 65 | 0.360 |
Why?
| | Endothelial Cells | 1 | 2016 | 703 | 0.350 |
Why?
| | Sensitivity and Specificity | 7 | 2021 | 1817 | 0.350 |
Why?
| | Software | 3 | 2014 | 608 | 0.350 |
Why?
| | Linear Models | 6 | 2017 | 816 | 0.340 |
Why?
| | Data Mining | 1 | 2011 | 110 | 0.340 |
Why?
| | Touch Perception | 2 | 2020 | 15 | 0.340 |
Why?
| | Feedback, Psychological | 3 | 2017 | 21 | 0.330 |
Why?
| | Artificial Intelligence | 1 | 2013 | 246 | 0.330 |
Why?
| | Multivariate Analysis | 5 | 2024 | 1499 | 0.330 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1490 | 0.330 |
Why?
| | Regression Analysis | 4 | 2015 | 982 | 0.320 |
Why?
| | Cerebrovascular Circulation | 2 | 2008 | 217 | 0.310 |
Why?
| | Self Concept | 4 | 2023 | 241 | 0.310 |
Why?
| | Image Enhancement | 3 | 2021 | 163 | 0.310 |
Why?
| | Hyperalgesia | 2 | 2024 | 109 | 0.300 |
Why?
| | Treatment Outcome | 11 | 2024 | 10162 | 0.300 |
Why?
| | Concept Formation | 1 | 2008 | 30 | 0.300 |
Why?
| | Periodicals as Topic | 1 | 2011 | 203 | 0.300 |
Why?
| | Substance-Related Disorders | 3 | 2024 | 1010 | 0.300 |
Why?
| | Statistics as Topic | 4 | 2017 | 304 | 0.280 |
Why?
| | Medicine | 1 | 2009 | 117 | 0.280 |
Why?
| | Sex Characteristics | 3 | 2014 | 722 | 0.280 |
Why?
| | Receptors, Opioid, mu | 1 | 2007 | 56 | 0.270 |
Why?
| | Signal Processing, Computer-Assisted | 4 | 2014 | 144 | 0.270 |
Why?
| | Animals | 15 | 2021 | 34647 | 0.270 |
Why?
| | Implosive Therapy | 2 | 2018 | 44 | 0.270 |
Why?
| | Nociceptors | 1 | 2006 | 20 | 0.260 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2006 | 32 | 0.260 |
Why?
| | Decision Making | 4 | 2022 | 847 | 0.250 |
Why?
| | Mind-Body Relations, Metaphysical | 1 | 2005 | 1 | 0.250 |
Why?
| | Mesencephalon | 4 | 2020 | 66 | 0.240 |
Why?
| | Classification | 1 | 2005 | 18 | 0.240 |
Why?
| | Weather | 1 | 2005 | 34 | 0.240 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 74 | 0.240 |
Why?
| | Double-Blind Method | 3 | 2024 | 1856 | 0.230 |
Why?
| | Virtual Reality Exposure Therapy | 1 | 2024 | 7 | 0.220 |
Why?
| | Ecological Momentary Assessment | 1 | 2024 | 32 | 0.220 |
Why?
| | Judgment | 3 | 2011 | 56 | 0.210 |
Why?
| | Research Design | 4 | 2024 | 1036 | 0.210 |
Why?
| | False Positive Reactions | 3 | 2019 | 113 | 0.210 |
Why?
| | Self-Management | 1 | 2025 | 161 | 0.200 |
Why?
| | Sample Size | 1 | 2023 | 115 | 0.200 |
Why?
| | Gambling | 1 | 2023 | 31 | 0.200 |
Why?
| | Comprehension | 2 | 2018 | 165 | 0.200 |
Why?
| | Anxiety Disorders | 2 | 2021 | 351 | 0.200 |
Why?
| | Drug Users | 1 | 2022 | 41 | 0.200 |
Why?
| | Support Vector Machine | 1 | 2022 | 37 | 0.200 |
Why?
| | Odorants | 1 | 2023 | 148 | 0.200 |
Why?
| | Nervous System | 2 | 2021 | 66 | 0.190 |
Why?
| | Politics | 1 | 2023 | 93 | 0.190 |
Why?
| | Disability Evaluation | 2 | 2022 | 285 | 0.190 |
Why?
| | Biological Variation, Population | 1 | 2021 | 20 | 0.190 |
Why?
| | Hypothalamus, Posterior | 1 | 2021 | 4 | 0.190 |
Why?
| | Antibodies, Neoplasm | 1 | 2021 | 35 | 0.190 |
Why?
| | Self Report | 3 | 2020 | 797 | 0.190 |
Why?
| | Attitude to Health | 1 | 2005 | 431 | 0.190 |
Why?
| | Escape Reaction | 1 | 2021 | 62 | 0.190 |
Why?
| | Visceral Pain | 1 | 2020 | 1 | 0.180 |
Why?
| | Motion Pictures | 1 | 2021 | 18 | 0.180 |
Why?
| | Psychology | 2 | 2020 | 81 | 0.180 |
Why?
| | Case-Control Studies | 6 | 2018 | 3339 | 0.180 |
Why?
| | Cluster Analysis | 2 | 2014 | 479 | 0.180 |
Why?
| | Computational Biology | 1 | 2025 | 597 | 0.180 |
Why?
| | Data Interpretation, Statistical | 2 | 2014 | 335 | 0.170 |
Why?
| | Imitative Behavior | 1 | 2020 | 4 | 0.170 |
Why?
| | Patient Reported Outcome Measures | 1 | 2024 | 370 | 0.170 |
Why?
| | Switzerland | 1 | 2020 | 35 | 0.170 |
Why?
| | Phagocytes | 1 | 2020 | 97 | 0.170 |
Why?
| | Cross-Cultural Comparison | 1 | 2020 | 82 | 0.170 |
Why?
| | Manipulation, Spinal | 1 | 2019 | 7 | 0.170 |
Why?
| | Sensory Thresholds | 2 | 2017 | 32 | 0.160 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2020 | 122 | 0.160 |
Why?
| | Neck Pain | 1 | 2019 | 26 | 0.160 |
Why?
| | China | 1 | 2020 | 190 | 0.160 |
Why?
| | Schizophrenia | 2 | 2014 | 428 | 0.160 |
Why?
| | Choice Behavior | 2 | 2011 | 165 | 0.160 |
Why?
| | Thoracic Vertebrae | 1 | 2019 | 74 | 0.160 |
Why?
| | Head Movements | 1 | 2019 | 20 | 0.160 |
Why?
| | Reading | 2 | 2014 | 150 | 0.160 |
Why?
| | Bias | 3 | 2017 | 196 | 0.160 |
Why?
| | Social Control, Formal | 1 | 2018 | 11 | 0.150 |
Why?
| | Electrocardiography | 2 | 2019 | 608 | 0.150 |
Why?
| | Personality | 1 | 2020 | 122 | 0.150 |
Why?
| | Auditory Cortex | 1 | 2018 | 41 | 0.150 |
Why?
| | Facial Recognition | 1 | 2019 | 30 | 0.150 |
Why?
| | Recidivism | 1 | 2018 | 4 | 0.150 |
Why?
| | Adiposity | 1 | 2023 | 504 | 0.150 |
Why?
| | Rest | 2 | 2017 | 120 | 0.150 |
Why?
| | Mitochondria | 1 | 2024 | 855 | 0.150 |
Why?
| | Acceptance and Commitment Therapy | 1 | 2018 | 27 | 0.150 |
Why?
| | Time Factors | 6 | 2021 | 6505 | 0.150 |
Why?
| | Genomics | 1 | 2023 | 715 | 0.150 |
Why?
| | Lymph Nodes | 1 | 2020 | 466 | 0.140 |
Why?
| | Behavior, Animal | 1 | 2021 | 502 | 0.140 |
Why?
| | Psychological Theory | 1 | 2018 | 99 | 0.140 |
Why?
| | Aged | 6 | 2024 | 21974 | 0.140 |
Why?
| | White Matter | 1 | 2019 | 134 | 0.140 |
Why?
| | Criminals | 1 | 2018 | 36 | 0.140 |
Why?
| | Neural Inhibition | 2 | 2017 | 152 | 0.140 |
Why?
| | Cardiovascular System | 2 | 2017 | 137 | 0.140 |
Why?
| | Attitude | 1 | 2019 | 251 | 0.140 |
Why?
| | Consciousness | 1 | 2017 | 25 | 0.140 |
Why?
| | Spatial Regression | 1 | 2017 | 1 | 0.140 |
Why?
| | Racism | 1 | 2020 | 129 | 0.140 |
Why?
| | Task Performance and Analysis | 3 | 2014 | 173 | 0.140 |
Why?
| | Adolescent Development | 1 | 2018 | 84 | 0.140 |
Why?
| | Cognitive Neuroscience | 1 | 2017 | 10 | 0.140 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2017 | 13 | 0.140 |
Why?
| | Acoustic Stimulation | 2 | 2018 | 328 | 0.140 |
Why?
| | Antisocial Personality Disorder | 1 | 2018 | 162 | 0.140 |
Why?
| | Wakefulness | 1 | 2018 | 120 | 0.130 |
Why?
| | Markov Chains | 2 | 2014 | 116 | 0.130 |
Why?
| | Models, Animal | 1 | 2018 | 367 | 0.130 |
Why?
| | Sleep Deprivation | 1 | 2019 | 171 | 0.130 |
Why?
| | Theory of Mind | 2 | 2017 | 13 | 0.130 |
Why?
| | Prejudice | 1 | 2017 | 69 | 0.130 |
Why?
| | Schizophrenic Psychology | 2 | 2014 | 93 | 0.130 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1332 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1412 | 0.130 |
Why?
| | Charities | 1 | 2016 | 11 | 0.130 |
Why?
| | E-Selectin | 1 | 2016 | 53 | 0.130 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2016 | 56 | 0.130 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 1938 | 0.130 |
Why?
| | B-Lymphocytes | 1 | 2021 | 814 | 0.130 |
Why?
| | Species Specificity | 2 | 2020 | 569 | 0.130 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 208 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2017 | 260 | 0.120 |
Why?
| | Resilience, Psychological | 1 | 2017 | 122 | 0.120 |
Why?
| | Sertraline | 1 | 2015 | 30 | 0.120 |
Why?
| | Respiratory Sinus Arrhythmia | 1 | 2015 | 15 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2021 | 803 | 0.120 |
Why?
| | Child Development | 1 | 2020 | 455 | 0.120 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2015 | 34 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 61 | 0.120 |
Why?
| | Ventral Striatum | 1 | 2015 | 9 | 0.120 |
Why?
| | Parietal Lobe | 1 | 2015 | 49 | 0.120 |
Why?
| | Vagus Nerve | 1 | 2015 | 85 | 0.120 |
Why?
| | Thalamus | 3 | 2019 | 85 | 0.120 |
Why?
| | Dominance, Cerebral | 2 | 2005 | 53 | 0.120 |
Why?
| | Psychotherapy | 1 | 2016 | 155 | 0.120 |
Why?
| | Cognition Disorders | 1 | 2018 | 498 | 0.110 |
Why?
| | Afferent Pathways | 1 | 2014 | 44 | 0.110 |
Why?
| | Thinking | 1 | 2014 | 56 | 0.110 |
Why?
| | Normal Distribution | 1 | 2014 | 21 | 0.110 |
Why?
| | Respiratory Rate | 1 | 2013 | 20 | 0.110 |
Why?
| | Reference Values | 2 | 2006 | 780 | 0.110 |
Why?
| | Signal-To-Noise Ratio | 1 | 2014 | 68 | 0.110 |
Why?
| | Speech | 2 | 2017 | 74 | 0.110 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2013 | 14 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1689 | 0.110 |
Why?
| | Sex Factors | 1 | 2019 | 1951 | 0.110 |
Why?
| | Anger | 1 | 2013 | 55 | 0.110 |
Why?
| | Arm | 1 | 2014 | 107 | 0.110 |
Why?
| | Hippocampus | 1 | 2018 | 832 | 0.110 |
Why?
| | Pattern Recognition, Visual | 2 | 2004 | 96 | 0.110 |
Why?
| | Craving | 2 | 2023 | 40 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 5371 | 0.100 |
Why?
| | Flow Cytometry | 1 | 2016 | 1142 | 0.100 |
Why?
| | Electric Stimulation | 3 | 2020 | 268 | 0.100 |
Why?
| | Skin | 1 | 2017 | 717 | 0.100 |
Why?
| | Injections, Intravenous | 1 | 2012 | 197 | 0.100 |
Why?
| | Sleep | 1 | 2018 | 682 | 0.100 |
Why?
| | Risk-Taking | 1 | 2015 | 347 | 0.100 |
Why?
| | Antipsychotic Agents | 1 | 2014 | 192 | 0.100 |
Why?
| | Logistic Models | 1 | 2017 | 1980 | 0.090 |
Why?
| | Polymorphism, Genetic | 1 | 2014 | 639 | 0.090 |
Why?
| | ROC Curve | 1 | 2013 | 502 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 1951 | 0.090 |
Why?
| | Life Change Events | 2 | 2014 | 147 | 0.090 |
Why?
| | Survivors | 1 | 2014 | 462 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2272 | 0.090 |
Why?
| | Disease Progression | 1 | 2018 | 2604 | 0.090 |
Why?
| | Parkinson Disease | 2 | 2014 | 461 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1712 | 0.090 |
Why?
| | Signal Detection, Psychological | 1 | 2010 | 23 | 0.080 |
Why?
| | Stroop Test | 2 | 2020 | 26 | 0.080 |
Why?
| | Genotype | 1 | 2014 | 1830 | 0.080 |
Why?
| | Psychosomatic Medicine | 1 | 2009 | 2 | 0.080 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2009 | 41 | 0.080 |
Why?
| | Somatoform Disorders | 1 | 2009 | 31 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2016 | 521 | 0.080 |
Why?
| | United States | 2 | 2023 | 13840 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2064 | 0.070 |
Why?
| | Neuroanatomy | 1 | 2008 | 9 | 0.070 |
Why?
| | Saccades | 2 | 2005 | 39 | 0.070 |
Why?
| | Lung | 1 | 2020 | 3748 | 0.070 |
Why?
| | Child | 4 | 2020 | 20805 | 0.070 |
Why?
| | Cooperative Behavior | 1 | 2010 | 424 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2013 | 1358 | 0.070 |
Why?
| | Dendritic Cells | 2 | 2021 | 477 | 0.070 |
Why?
| | Carbon Radioisotopes | 1 | 2007 | 35 | 0.070 |
Why?
| | Phobic Disorders | 1 | 2007 | 31 | 0.070 |
Why?
| | Data Collection | 1 | 2010 | 649 | 0.070 |
Why?
| | Limbic System | 1 | 2007 | 46 | 0.070 |
Why?
| | Inflammation | 1 | 2018 | 2666 | 0.070 |
Why?
| | Field Dependence-Independence | 1 | 2007 | 4 | 0.070 |
Why?
| | Perceptual Masking | 1 | 2007 | 13 | 0.070 |
Why?
| | Space Perception | 2 | 2007 | 76 | 0.070 |
Why?
| | Cerebral Arteries | 1 | 2007 | 57 | 0.070 |
Why?
| | Databases, Factual | 3 | 2020 | 1267 | 0.070 |
Why?
| | Internet | 1 | 2011 | 613 | 0.070 |
Why?
| | Models, Biological | 1 | 2014 | 1698 | 0.070 |
Why?
| | Principal Component Analysis | 2 | 2017 | 182 | 0.070 |
Why?
| | Avoidance Learning | 2 | 2022 | 68 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5281 | 0.070 |
Why?
| | Aggression | 1 | 2008 | 195 | 0.070 |
Why?
| | Fentanyl | 1 | 2007 | 76 | 0.070 |
Why?
| | Prospective Studies | 2 | 2016 | 7069 | 0.060 |
Why?
| | Radiography | 3 | 2013 | 795 | 0.060 |
Why?
| | Neurobiology | 1 | 2005 | 15 | 0.060 |
Why?
| | Neocortex | 1 | 2006 | 33 | 0.060 |
Why?
| | Mathematical Computing | 1 | 2005 | 11 | 0.060 |
Why?
| | Logic | 1 | 2005 | 6 | 0.060 |
Why?
| | Lasers | 1 | 2006 | 132 | 0.060 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 72 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2710 | 0.060 |
Why?
| | Discrimination Learning | 1 | 2004 | 53 | 0.060 |
Why?
| | Catastrophization | 1 | 2024 | 11 | 0.060 |
Why?
| | Orientation | 1 | 2004 | 44 | 0.060 |
Why?
| | Memory | 1 | 2006 | 254 | 0.060 |
Why?
| | Electroshock | 1 | 2004 | 147 | 0.050 |
Why?
| | Mitochondrial Diseases | 1 | 2024 | 90 | 0.050 |
Why?
| | Recruitment, Neurophysiological | 2 | 2014 | 47 | 0.050 |
Why?
| | Adaptation, Psychological | 1 | 2008 | 617 | 0.050 |
Why?
| | Behavior, Addictive | 1 | 2024 | 81 | 0.050 |
Why?
| | Verbal Learning | 1 | 2003 | 64 | 0.050 |
Why?
| | DNA, Mitochondrial | 1 | 2024 | 190 | 0.050 |
Why?
| | Self-Assessment | 1 | 2023 | 68 | 0.050 |
Why?
| | Fourier Analysis | 1 | 2003 | 39 | 0.050 |
Why?
| | Virtual Reality | 1 | 2024 | 51 | 0.050 |
Why?
| | Analysis of Variance | 3 | 2011 | 1273 | 0.050 |
Why?
| | Poisson Distribution | 2 | 2014 | 73 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 125 | 0.050 |
Why?
| | Cholecystokinin | 1 | 2021 | 14 | 0.050 |
Why?
| | Calibration | 1 | 2022 | 135 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 134 | 0.050 |
Why?
| | Aversive Agents | 1 | 2021 | 2 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2023 | 222 | 0.050 |
Why?
| | Facial Pain | 1 | 2021 | 13 | 0.040 |
Why?
| | Capsaicin | 1 | 2021 | 25 | 0.040 |
Why?
| | Antigens, CD1 | 1 | 2020 | 58 | 0.040 |
Why?
| | Interferon Type I | 1 | 2021 | 140 | 0.040 |
Why?
| | Fatigue | 1 | 2022 | 316 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2018 | 1003 | 0.040 |
Why?
| | Neostriatum | 1 | 2020 | 34 | 0.040 |
Why?
| | Mice | 3 | 2021 | 16620 | 0.040 |
Why?
| | Optogenetics | 1 | 2021 | 112 | 0.040 |
Why?
| | Skin Cream | 1 | 2019 | 12 | 0.040 |
Why?
| | Dyspnea | 1 | 2021 | 239 | 0.040 |
Why?
| | Education | 1 | 2020 | 100 | 0.040 |
Why?
| | Anisotropy | 1 | 2019 | 71 | 0.040 |
Why?
| | Weight Gain | 1 | 2023 | 504 | 0.040 |
Why?
| | Headache | 1 | 2020 | 149 | 0.040 |
Why?
| | Diffusion Tensor Imaging | 1 | 2019 | 73 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 336 | 0.040 |
Why?
| | Informatics | 1 | 2018 | 7 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 336 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2023 | 626 | 0.040 |
Why?
| | Taste | 1 | 2021 | 213 | 0.040 |
Why?
| | Neuroimmunomodulation | 1 | 2018 | 69 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2021 | 427 | 0.040 |
Why?
| | Electroencephalography | 1 | 2020 | 396 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 344 | 0.040 |
Why?
| | Motor Activity | 2 | 2017 | 669 | 0.040 |
Why?
| | Monocytes | 1 | 2020 | 546 | 0.040 |
Why?
| | Discriminant Analysis | 1 | 2017 | 38 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 624 | 0.040 |
Why?
| | Stochastic Processes | 1 | 2017 | 66 | 0.030 |
Why?
| | Cell Membrane | 1 | 2020 | 725 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1018 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2069 | 0.030 |
Why?
| | Prisoners | 1 | 2018 | 141 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 7057 | 0.030 |
Why?
| | Pharmacogenomic Testing | 1 | 2016 | 60 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 252 | 0.030 |
Why?
| | Autistic Disorder | 1 | 2017 | 186 | 0.030 |
Why?
| | Occipital Lobe | 1 | 2014 | 24 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2765 | 0.030 |
Why?
| | Antiparkinson Agents | 1 | 2014 | 28 | 0.030 |
Why?
| | September 11 Terrorist Attacks | 1 | 2014 | 31 | 0.030 |
Why?
| | Probability Learning | 1 | 2013 | 2 | 0.030 |
Why?
| | RNA | 1 | 2020 | 881 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 3178 | 0.030 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2015 | 236 | 0.030 |
Why?
| | Risk Factors | 2 | 2018 | 9737 | 0.030 |
Why?
| | Impulsive Behavior | 1 | 2015 | 128 | 0.030 |
Why?
| | Genetic Markers | 1 | 2014 | 338 | 0.030 |
Why?
| | PubMed | 1 | 2013 | 10 | 0.030 |
Why?
| | Rats | 1 | 2021 | 5246 | 0.030 |
Why?
| | Macrophages | 1 | 2020 | 1464 | 0.030 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 482 | 0.030 |
Why?
| | Psychometrics | 1 | 2016 | 682 | 0.020 |
Why?
| | Comorbidity | 1 | 2016 | 1541 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 842 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2014 | 383 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5402 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2516 | 0.020 |
Why?
| | Psychophysics | 1 | 2010 | 13 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 3122 | 0.020 |
Why?
| | Obesity | 1 | 2023 | 2864 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 131 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5045 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5740 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3051 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1568 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2011 | 252 | 0.020 |
Why?
| | Probability | 1 | 2009 | 306 | 0.020 |
Why?
| | Personality Inventory | 1 | 2008 | 137 | 0.020 |
Why?
| | Cortical Synchronization | 1 | 2007 | 9 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2009 | 196 | 0.020 |
Why?
| | Gastrointestinal Tract | 1 | 2009 | 183 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2719 | 0.020 |
Why?
| | Social Control, Informal | 1 | 2005 | 20 | 0.020 |
Why?
| | Form Perception | 1 | 2004 | 11 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 10487 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2009 | 2001 | 0.010 |
Why?
|
|
Wager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|